We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

47 hedge funds and large institutions have $16.3M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

0% more funds holding

Funds holding: 47 → 47 (0)

0% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 10

34% less capital invested

Capital invested by funds: $24.7M → $16.3M (-$8.38M)

Holders
47
Holders Change
–
Holders Change %
0%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
10
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Mariner
Mariner
Kansas
+$279K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$46K
3
FA
Forefront Analytics
Pennsylvania
+$28.7K
4
Jane Street
Jane Street
New York
+$13.1K
5
Goldman Sachs
Goldman Sachs
New York
+$8.94K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$1.67M
2
BlackRock
BlackRock
New York
-$356K
3
Renaissance Technologies
Renaissance Technologies
New York
-$306K
4
UOC
UBS O'Connor
Illinois
-$216K
5
Verition Fund Management
Verition Fund Management
Connecticut
-$25K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$6.79K -$23.5K -5,320 -74%
UBS Group
27
UBS Group
Switzerland
$6.23K +$5.76K +1,303 +342%
SG
28
StoneX Group
New York
$5.57K +$6.63K +1,500 New
HIC
29
Holderness Investments Company
North Carolina
$5.46K – – –
IIA
30
IPG Investment Advisors
California
$5.23K – – –
Wells Fargo
31
Wells Fargo
California
$4.64K – – –
OC
32
Oppenheimer & Co
New York
$4.27K -$88 -20 -2%
LG
33
Lane Generational
Massachusetts
$4.02K +$4.79K +1,083 New
IAA
34
Ironsides Asset Advisors
North Carolina
$4K -$31 -7 -0.7%
HighTower Advisors
35
HighTower Advisors
Illinois
$4K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$4K +$3.94K +890 +1,187%
VF
37
Virtu Financial
New York
$4K +$5.31K +1,202 New
CWM
38
Connecticut Wealth Management
Connecticut
$3.71K – – –
Osaic Holdings
39
Osaic Holdings
Arizona
$3.09K +$2.27K +514 +260%
Barclays
40
Barclays
United Kingdom
$742 – – –
Citigroup
41
Citigroup
New York
$408 -$35 -8 -7%
CWP
42
Concord Wealth Partners
Virginia
$371 +$442 +100 New
BHWM
43
Beaird Harris Wealth Management
Texas
$45 – – –
MAWCM
44
Mine & Arao Wealth Creation & Management
California
$37 – – –
AAG
45
Armstrong Advisory Group
Massachusetts
$19 +$22 +5 New
BlackRock
46
BlackRock
New York
– -$356K -71,200 Closed
UOC
47
UBS O'Connor
Illinois
– -$216K -43,298 Closed
Verition Fund Management
48
Verition Fund Management
Connecticut
– -$25K -5,000 Closed
Balyasny Asset Management
49
Balyasny Asset Management
Illinois
– -$17K -3,372 Closed
RPCA
50
Running Point Capital Advisors
California
– -$5K -1,000 Closed
1
2
3

ORTX Hedge Fund Activity: Q4 2022 in Review

47 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q4 2022, worth a combined $16.3M — down 34% from $24.7M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ORTX positions and 6 closed out — a net gain of 2 holders — while 10 added to existing stakes and 10 trimmed.

The largest buyer was Mariner, opening a new position worth an estimated $279K. The largest seller was Deerfield Management, cutting an estimated $1.67M.

  • 47 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $16.3M of Orchard Therapeutics plc American Depositary Shares stock for Q4 2022, down 34% quarter-over-quarter.
  • 8 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q4 2022 and 6 closed out, a net change of +2 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q4 2022 was Mariner, an estimated $279K added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q4 2022 was Deerfield Management, an estimated $1.67M sold.

Based on aggregated 13F filings for Q4 2022.